Animation production and an ideal animation studio design
2004
0 views
0 downloads
Advisor: Yrd. Doç. Dr. Erkan Büker
Abstract (EN)
Animation is an art form and a subject of science which has began researching in universities. Being an art form and a subject of science, animation needs to be taken from different perspectives. Besides it is an art form and a subject of science, animation has became an industry. Production of animation, by the artist has become a product of science and technology. This research deals with the production states, the fields, the history, the evolution, the development, the producing artists and the structure of the production companies. By the help of consumption power of the cinema industry, the animation studios are developing day by day. The structure of these successful companies have been examined during the research. It also examines the animation studios in Turkey which has failed to industrialize and the studios which are on the way to be industrialized. A design of an ideal animation studio, presented in consern of Turkey's economical and socio-cultural state acording to the studies and resarches. IV
Author
Mesut Mert Uçkan
How to Cite
Mesut Mert Uçkan (Master Thesis). Animation production and an ideal animation studio design, 2004, Yeditepe University.
License
Tüm Hakları Saklıdır
This work is shared under the specified license terms.
More theses from Yeditepe University
- Studies on cyclodextrin complexation of a poorly water soluble anti-hyperlipidemic drug, tablet formulation and characterization(2021)
- Washington ambassadors in Turkish-US relations (1927-1960)(2023)
- Metamorphosis of female voices: A study of the violation of women in Greek and Roman mythology and feminist rewritings reclaiming the narrative(2022)
- Knowledge distillation with foundation models for image segmentation(2023)
- The relationship between machiavelism, grandiose and vulnerable narcissism, and loneliness among white collar workers(2023)
- Evaluation of drug-drug interaction checkers along clinically relevant adverse drug events in oncology and hematology pediatric patients(2023)